Arcadia Biosciences在400万美元的私人配售中下跌8%

• Arcadia Biosciences (RKDA) entered into securities purchase agreements for a private placement consisting of ~3.88M shares of common stock, along with Series A-1 and Series A-2 preferred investment options to purchase same number of shares each, at a price of $1.03 per share.
• The offering is expected to raise about $4M in gross proceeds before fees and expenses.
• Arcadia (RKDA) said it plans to use the net proceeds for working capital and general corporate purposes.
• The offering is expected to close on or about June 12.
• The stock price traded about 8% lower on Friday during pre-market hours.

More on Arcadia Biosciences

• Historical earnings data for Arcadia Biosciences
• Financial information for Arcadia Biosciences